Spots Global Cancer Trial Database for epithelial ovarian cancer
Every month we try and update this database with for epithelial ovarian cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer | NCT06068738 | Epithelial Ovar... | Biological samp... | 18 Years - 125 Years | Exscientia AI Limited | |
| Prevention of Ovarian Cancer in Women Participating in Mammography | NCT01851109 | Epithelial Ovar... | genetic counsel... | 35 Years - | Fred Hutchinson Cancer Center | |
| Determining Prognostic Immune Markers in Patients With Ovarian Cancer | NCT03862677 | Epithelial Ovar... | No intervention | 18 Years - | Leiden University Medical Center | |
| A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer | NCT01649336 | Epithelial Ovar... Fallopian Tube ... Peritoneal Canc... | MEK162, MEK inh... Paclitaxel, mit... | 18 Years - | Array BioPharma | |
| Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer | NCT01238770 | Epithelial Ovar... | Pazopanib | 18 Years - | University Hospital Heidelberg | |
| Study of Safety & Biological Activity of IP IMNN-001 (Also Known as GEN-1) With Neoadjuvant Chemo in Ovarian Cancer | NCT02480374 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | IMNN-001 | 18 Years - | Imunon | |
| A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer | NCT04651920 | Epithelial Ovar... Chinese Homologous Reco... BRCA1 Mutation BRCA2 Mutation Prognosis Homologous Reco... | Evaluation of h... | 18 Years - | Peking Union Medical College Hospital | |
| Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) to Treat Platinum-sensitive Ovarian Cancer | NCT01004380 | Epithelial Ovar... | Farletuzumab, C... | 18 Years - | Morphotek | |
| Real-world Study of Niraparib Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer | NCT04986371 | Epithelial Ovar... | Niraparib | 18 Years - | ChineseAMS | |
| Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00317772 | Ovarian Cancer Peritoneal Neop... Fallopian Tube ... | Topotecan Gefitinib | - | M.D. Anderson Cancer Center | |
| Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand | NCT01549925 | Epithelial Ovar... | Standard Surgic... LIGASURE | 18 Years - | University of Utah | |
| Study of RO7515629 in Participants With HLA-G Positive Solid Tumors | NCT05769959 | Renal Cell Carc... Non-small Cell ... Pancreatic Aden... Colorectal Canc... Ovarian Neoplas... | RO7515629 tocilizumab | 18 Years - | Hoffmann-La Roche | |
| LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer | NCT02668913 | Epithelial Ovar... Peritoneal Canc... Fallopian Tube ... Gynaecological ... | Diagnostic anal... | 18 Years - | University of Leeds | |
| A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer | NCT06010667 | Epithelial Ovar... | Envafolimab | 18 Years - 70 Years | Hebei Medical University Fourth Hospital | |
| A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer | NCT00880360 | Epithelial Ovar... Extraovarian Pe... Fallopian Tube ... | Ontak | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis | NCT04000906 | Peritoneal Carc... | Nab paclitaxel Cisplatin | 18 Years - | University Hospital, Geneva | |
| Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer | NCT00281515 | Epithelial Ovar... | Lonafarnib | 18 Years - | AGO Study Group | |
| Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study | NCT01617629 | Epithelial Ovar... | MUC1 Dendritic ... | 18 Years - | Prima BioMed Ltd | |
| Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) | NCT02859038 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Upfront cytored... Interval debulk... | 18 Years - | Shanghai Gynecologic Oncology Group | |
| Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status | NCT01690598 | Ovarian Cancer | Veliparib Topotecan | 18 Years - | Vejle Hospital | |
| WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC | NCT04644289 | Epithelial Ovar... | olaparib durvalumab | 18 Years - | AGO Research GmbH | |
| Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients | NCT03933813 | Epithelial Ovar... Anemia Iron Deficiency... | Iron Sucrose | 18 Years - | University of Wisconsin, Madison | |
| A Training Set for the HRD Model in EOC | NCT04651933 | Epithelial Ovar... BRCA Mutation Loss of Heteroz... Prognosis Platinum Resist... Homologous Reco... | Homologous reco... | 18 Years - | Peking Union Medical College Hospital | |
| Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer | NCT06386887 | Epithelial Ovar... | Intermittent Fa... Neoadjuvant che... | 18 Years - | Case Comprehensive Cancer Center | |
| A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation | NCT04473339 | Ovarian Cancer Epithelial Ovar... Ovarian Cancer,... Hyperthermic In... Homologous Reco... | CRS+HIPEC CRS alone | 18 Years - 75 Years | Zhongnan Hospital | |
| The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer | NCT02856841 | Ovarian Cancer | 20 Years - 60 Years | Cairo University | ||
| Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00317772 | Ovarian Cancer Peritoneal Neop... Fallopian Tube ... | Topotecan Gefitinib | - | M.D. Anderson Cancer Center | |
| A Study of ZN-c3 in Patients With Ovarian Cancer | NCT04516447 | Solid Tumor Epithelial Ovar... Fallopian Tube ... Peritoneal Canc... | ZN-c3 Carboplatin Pegylated lipos... Paclitaxel Gemcitabine Bevacizumab | 18 Years - | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | |
| Administration of Hyperthermic Intraperitoneal Chemotherapy in the General Ward | NCT06277947 | Epithelial Ovar... | China Hyperther... | 18 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Development of a Biomarker to Predict the Efficacy of Anti-angiogenic Therapy in Ovarian Cancer | NCT05874115 | Epithelial Ovar... | liquid biopsy | 18 Years - | Centro di Riferimento Oncologico - Aviano | |
| Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer | NCT02312661 | Epithelial Ovar... | Metformin Carboplatin Paclitaxel | 18 Years - | University Medical Center Groningen | |
| Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy | NCT05877911 | Epithelial Ovar... Acute Kidney In... | Sodium Sulfate Hydration Cisplatin | - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Paclitaxel i.v. Plus Cisplatin i.p for NACT in Patients With Advanced Ovarian Cancer | NCT04885270 | Epithelial Carc... Neoadjuvant Che... | cisplatin i.p. | 18 Years - 75 Years | West China Second University Hospital | |
| A Study of Long-Term Responders on Olaparib | NCT02489058 | Epithelial Ovar... Fallopian Tube ... Peritoneal Canc... | 18 Years - | University Health Network, Toronto | ||
| Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer | NCT04670978 | Objective Respo... | albumin-bound p... | 18 Years - 70 Years | Shandong University | |
| Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission | NCT02324439 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Omega Nutrition... | 21 Years - | Southern Illinois University | |
| The INFLUENCE of Cytoreduction on PRO in EOC | NCT03268876 | Epithelial Ovar... | 18 Years - 100 Years | Haukeland University Hospital | ||
| LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer | NCT02668913 | Epithelial Ovar... Peritoneal Canc... Fallopian Tube ... Gynaecological ... | Diagnostic anal... | 18 Years - | University of Leeds | |
| Real-world Study of Niraparib Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer | NCT04986371 | Epithelial Ovar... | Niraparib | 18 Years - | ChineseAMS | |
| Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel | NCT01000896 | Cancer Non Small Cell ... Epithelial Ovar... | AZD0530 Carboplatin paclitaxel | 20 Years - | AstraZeneca | |
| A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies | NCT05199272 | Solid Tumor Clear Cell Rena... Epithelial Ovar... Fallopian Tube ... Primary Periton... Neuroendocrine ... MSI-H Cancer Cancer With A H... Extensive-stage... | 23ME-00610 | 12 Years - | 23andMe, Inc. | |
| A Study of Safety and Efficacy of KFA115 Alone and in Combination With Pembrolizumab in Patients With Select Advanced Cancers | NCT05544929 | Carcinoma, Non-... Cutaneous Melan... Carcinoma, Rena... Carcinoma, Ovar... Nasopharyngeal ... Carcinoma, Thym... Anal Cancer Mesothelioma Esophagogastric... High Microsatel... Squamous Cell C... Triple Negative... | KFA115 pembrolizumab | 18 Years - | Novartis | |
| Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors | NCT02644369 | Squamous Cell C... Triple Negative... Epithelial Ovar... Malignant Melan... Advanced Solid ... | Pembrolizumab | 18 Years - | University Health Network, Toronto | |
| Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial | NCT01506856 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Paclitaxel(intr... Paclitaxel(intr... | 20 Years - | Gynecologic Oncology Trial & Investigation Consortium | |
| Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer | NCT01680575 | Epithelial Ovar... | 20 Years - 80 Years | Asan Medical Center | ||
| Salvage Ovarian FANG™ Vaccine + Bevacizumab | NCT01551745 | Stage III Ovari... Stage IV Ovaria... | Vigil™ Vaccine Bevacizumab | 18 Years - | Gradalis, Inc. | |
| Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma | NCT00226915 | Epithelial Ovar... Primary Periton... Fallopian Tube ... | Paclitaxel+Carb... Paclitaxel+Carb... | 20 Years - | Japanese Gynecologic Oncology Group | |
| A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) | NCT05429970 | Ovarian Cancer Ovarian Carcino... Stage II Ovary ... Stage II Ovaria... Stage III Ovary... Stage III Ovari... Stage IV Ovary ... Stage IV Ovaria... Epithelial Ovar... Fallopian Tube ... Stage II Fallop... Stage III Fallo... Stage IV Fallop... Primary Periton... | Mind-body resil... Music therapy Propranolol Etodolac | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor | NCT00543049 | Platinum Refrac... Primary Cancer ... Cancer of the F... | Sunitinib SUNITINIB | 18 Years - | AGO Study Group | |
| Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) | NCT02859038 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Upfront cytored... Interval debulk... | 18 Years - | Shanghai Gynecologic Oncology Group | |
| Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy | NCT05877911 | Epithelial Ovar... Acute Kidney In... | Sodium Sulfate Hydration Cisplatin | - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer | NCT02606305 | Epithelial Ovar... Primary Periton... Fallopian Tube ... | Mirvetuximab so... Bevacizumab Carboplatin Pegylated Lipos... Pembrolizumab | 18 Years - | ImmunoGen, Inc. | |
| Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery | NCT03373058 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Hyperthermic In... cytoreductive s... adjuvant chemot... | 18 Years - 70 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation | NCT02477202 | Epithelial Ovar... | Mirena® intra-u... | 35 Years - 50 Years | Memorial Sloan Kettering Cancer Center | |
| PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer | NCT05187208 | Epithelial Ovar... Ovarian Cancer Ovarian Cancer ... Ovarian Cancer ... | Niraparib | 20 Years - | Seoul National University Hospital | |
| A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy | NCT01840943 | Epithelial Ovar... | CAELYX Topotecan HCl | 18 Years - | Xian-Janssen Pharmaceutical Ltd. | |
| Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission | NCT02324439 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Omega Nutrition... | 21 Years - | Southern Illinois University | |
| Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors | NCT04429542 | Head and Neck S... Squamous Cell C... Colorectal Canc... Squamous Cell C... EGFR Amplificat... Epithelial Ovar... Pancreas Cancer Cutaneous Squam... Head and Neck N... Carcinoma, Squa... Squamous Cell C... | BCA101 Pembrolizumab | 18 Years - | Bicara Therapeutics | |
| CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib | NCT04676334 | Metastatic Cast... Ovarian Cancer Epithelial Ovar... Fallopian Tube ... Peritoneal Canc... Other Solid Tum... | Rucaparib | 18 Years - | pharmaand GmbH | |
| Microscopic Peritoneal Metastases After Complete Macroscopic Cytoreductive Surgery for Epithelial Ovarian Cancer | NCT03754569 | Epithelial Ovar... | Peritoneal biop... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients | NCT00583622 | Ovarian Cancer | Bevacizumab Carboplatin Docetaxel Gemcitabine Melphalan Stem Cell Trans... | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer | NCT03587129 | Ovarian Cancer | Apatinib | 18 Years - | First Affiliated Hospital of Harbin Medical University | |
| Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer | NCT00850772 | Epithelial Ovar... Peritoneal Canc... Fallopian Tube ... | Early post-oper... | 18 Years - | Queensland Centre for Gynaecological Cancer | |
| Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer | NCT01442051 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Acute Normovole... | 18 Years - 69 Years | Memorial Sloan Kettering Cancer Center | |
| Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer | NCT01238770 | Epithelial Ovar... | Pazopanib | 18 Years - | University Hospital Heidelberg | |
| A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure | NCT05489926 | Epithelial Ovar... | Pamiparib | 18 Years - | Zhejiang Cancer Hospital | |
| Cukurova Score Validation Study | NCT06378905 | Epithelial Ovar... Primary Cytored... | 18 Years - 100 Years | Cukurova University | ||
| Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs. | NCT02323568 | Epithelial Ovar... | Gynecological c... | 18 Years - | Centre Francois Baclesse | |
| A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) | NCT03824704 | Epithelial Ovar... Fallopian Tube ... Primary Periton... High Grade Sero... Endometrioid Ad... | Rucaparib Nivolumab | 18 Years - | pharmaand GmbH | |
| Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer | NCT00850772 | Epithelial Ovar... Peritoneal Canc... Fallopian Tube ... | Early post-oper... | 18 Years - | Queensland Centre for Gynaecological Cancer | |
| Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN) | NCT05855941 | Cervix Cancer Endometrial Can... Epithelial Ovar... | FDG-PET/CT and ... | 18 Years - | Region Västerbotten | |
| Study of JK08 in Patients With Unresectable Locally Advanced or Metastatic Cancer | NCT05620134 | Cancer Tumor, Solid Advanced Solid ... Metastatic Canc... Melanoma Colorectal Canc... Non-small Cell ... Small-cell Lung... Urothelial Carc... Squamous Cell C... Luminal Breast ... Triple Negative... Clear Cell Rena... Papillary Renal... Gastric Adenoca... GastroEsophagea... Squamous Cell C... Pancreatic Aden... Hepatocellular ... Colorectal Aden... Epithelial Ovar... Thyroid Cancer | JK08 Pembrolizumab | 18 Years - | Salubris Biotherapeutics Inc | |
| Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study | NCT00715286 | Ovarian Carcino... | timing of surge... timing of surge... | 20 Years - 65 Years | All India Institute of Medical Sciences, New Delhi | |
| Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer | NCT05272462 | Ovarian Cancer | Minoxidil | 18 Years - 90 Years | Loyola University | |
| A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) | NCT01891344 | Ovarian Cancer Epithelial Ovar... Fallopian Tube ... Peritoneal Canc... | Oral rucaparib | 18 Years - | pharmaand GmbH | |
| Pathogenic Variants in Homologous Recombination Repair Genes in Patients With Epithelial Ovarian Cancer | NCT04716374 | Epithelial Ovar... | Tumor molecular... | 18 Years - | Hellenic Cooperative Oncology Group | |
| Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence | NCT05856409 | 68Ga-FAPI Ovarian Cancer Epithelial Ovar... Positron Emissi... | 68Ga-FAPI | 18 Years - 80 Years | RenJi Hospital | |
| Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand | NCT01549925 | Epithelial Ovar... | Standard Surgic... LIGASURE | 18 Years - | University of Utah | |
| WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC | NCT04644289 | Epithelial Ovar... | olaparib durvalumab | 18 Years - | AGO Research GmbH | |
| Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study | NCT00968799 | Epithelial Ovar... Fallopian Tube ... | Hyperthermic in... Cytoreduction Cisplatin | 18 Years - 70 Years | Cantonal Hospital of St. Gallen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
